Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

 

 

Volume: 23S5 • October 1997

Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers
1997


 

Notice:
For those viewers who downloaded the Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers, 1997, prior to November 18, 1997, please note the following change in Appendix I. The malaria risk information for Brazil should be replaced with the following:
"Rural areas of Acre, Amazonas, Goias, Maranhao, Mato Grosso and Para States; and territories of Tocantins, Amapa, Rondonia, Roraima. Note: No risk for travellers to coastal states from the horn to Uruguay border and Iguassu Falls."

Table of Contents

PREFACE

1. INTRODUCTION

2. PREVENTION

  1. Risk of Acquiring Malaria
  2. Personal Measures to Prevent Mosquitos
  3. Chemosuppressive Drugs (where appropriate)
  4. Early Diagnosis and Treatment

3. CHEMOSUPPRESSIVE REGIMENS

  1. Introduction
  2. Chloroquine-Sensitive Zones
  3. Chloroquine-Resistant Zones
  4. Chloroquine- and Mefloquine-Resistant Zones

4. SELF TREATMENT OF PRESUMPTIVE MALARIA

5. PREVENTION OF MALARIA IN SPECIAL HOSTS

  1. Malaria Prevention in Children
  2. Malaria Prevention in Pregnancy


  3. Recommendations

6. DIAGNOSIS OF MALARIA

7. TREATMENT OF MALARIA

  1. General Principles of Management
  2. Management of Falciparum Malaria
  3. Ancillary Treatment for Severe Malaria
  4. Management of Non-Falciparum Malaria
  5. Prevention of Relapses of Malaria Due to P. vivax or P. ovale
  6. P. vivax

8. NEW DRUGS FOR PREVENTION AND TREATMENT OF MALARIA

  1. Halofantrine

    Recommendations


  2. Artemisnin Derivatives (Qinghaosu) for the Treatment of Drug-Resistant Malaria

    Recommendations

  3. Atovaquone/Proguanil (Malarone®) for Treatment and Chemosuppression
    Recommendations

  4. Primaquine for Chemoprophylaxis

    Recommendations

APPENDIX I: MALARIA RISK BY GEOGRAPHIC AREAS IN COUNTRIES WITH ENDEMIC MALARIA

APPENDIX II: CATEGORIES FOR STRENGTH AND QUALITY OF EVIDENCE FOR EACH RECOMMENDATION

APPENDIX III: CHECKLIST FOR TRAVELLERS TO MALARIOUS AREAS

 

[Table of Contents] [Next]

Last Updated: 1997-11-04 Top